Historical record - last NADAC effective date: 9/20/2023
Product Information
AMLODIPINE-ATORVAST 10-20 MG is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $1.5050 per EA under NDC 43598031830. Its NADAC has been published 495 times since May 14, 2014.
FDA first approved this application on Mar 7, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 20 mg/1; mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598031830
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/20/2023
Active Ingredients
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA203874FDA Approved
3/7/2014
TE Code
AB
On Market Since
3/17/2014
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-ATORVAST 10-20 MG has been published 495 times since May 14, 2014, and over the history we have for it it has declined 77.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5050 per EA |
|---|---|
| All-time high | $6.9238 (Jul 16, 2014) |
| All-time low | $0.7277 (Oct 19, 2022) |
| Median price | $3.4125 |
| Average price | $3.6467 |
| Largest weekly change | +120.1% (Dec 21, 2022) |
| Weeks tracked | 495 |
| Tracking since | May 14, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-27.9%
5Y
-57.8%
All
-77.4%
Last surveyed Nov 1, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-ATORVAST 10-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 10-20 MG, manufactured by Dr. Reddy's Laboratories Inc., is $1.5050 per EA (NDC 43598031830), effective Nov 1, 2023.
How has the price of AMLODIPINE-ATORVAST 10-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 10-20 MG has declined 77.4%. It has been tracked across 495 weekly CMS publications since May 14, 2014.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 10-20 MG?
Since May 14, 2014, the NADAC for AMLODIPINE-ATORVAST 10-20 MG has ranged from a low of $0.7277 (Oct 19, 2022) to a high of $6.9238 (Jul 16, 2014), with a median of $3.4125 per EA.
Are there cheaper alternatives to AMLODIPINE-ATORVAST 10-20 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-ATORVAST 10-20 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-ATORVAST 10-20 MG?
AMLODIPINE-ATORVAST 10-20 MG (NDC 43598031830) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.